Published June 9, 2020
| Version v1
Patent
Open
Prognostic and predictive breast cancer signature
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating a specified set of genes. Specifically, methods may comprise calculating a prognosis score based on a particular algorithm. Also disclosed are compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more upstream activators and/or downstream effectors of TET1.
Files
US10679730.pdf
Files
(4.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6e04880cdf03b45d4dfa2be5aaa73c11
|
4.8 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10679730 B2
- Patent application number
- US 201514952265 A
- Other
- oai:uchicago.tind.io:7405
Dates
- Patent filed
-
2015-11-25